ARRB2 and polycystic ovary syndrome: Proteomic analyses demonstrate that DZXY modulates the β-arr2-mediated signaling cascade by enhancing β-arr2 expression, hence contributing to the prevention and management of polycystic ovarian syndrome (Zhang et al., 2013).